ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ICU SeaStar Medical Holding Corporation

0.4551
-0.0382 (-7.74%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
SeaStar Medical Holding Corporation ICU NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0382 -7.74% 0.4551 23:00:10
Open Price Low Price High Price Close Price Previous Close
0.49 0.4421 0.5093 0.4486 0.4933
more quote information »

Recent News

Date Time Source Heading
4/30/202407:30GLOBESeaStar Medical Announces $3.6 Million NIH Grant Award to..
4/17/202415:00GLOBESeaStar Medical Reports 2023 Financial Results and Provides..
4/11/202407:30GLOBESeaStar Medical to Present at the Noble Capital Markets’..
3/27/202407:30GLOBESeaStar Medical to Restate Financials, Sets Business Update..
3/12/202407:30GLOBESeaStar Medical Provides Updates on Enrollment of Adult..
3/11/202415:05GLOBESeaStar Medical-Sponsored Symposium Featuring Experts..
2/27/202407:30GLOBEManuscript Discussing the Benefit of SeaStar Medical’s..
2/22/202406:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
2/22/202406:53GLOBEFDA Grants Humanitarian Device Exemption Approval to SeaStar..
2/01/202407:30GLOBESeaStar Medical Granted Canadian Patent with Broad Claims..
1/26/202407:05GLOBESeaStar Medical Announces Pricing of $9.0 Million Registered..
1/11/202415:05GLOBESeaStar Medical Appoints David A. Green as Chief Financial..
1/09/202407:30GLOBESeaStar Medical Issued U.S. Patent with Broad Claims..
12/28/202307:30GLOBESeaStar Medical Updates Subject Enrollment in its Pivotal..
12/13/202307:30GLOBESeaStar Medical Forms Scientific Advisory Board of..
11/14/202315:04GLOBESeaStar Medical Reports Third Quarter 2023 Financial Results..
10/31/202307:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
10/30/202307:00GLOBEFDA Issues Approvable Letter for SeaStar Medical’s Selective..
10/18/202307:30GLOBEFDA Grants SeaStar Medical’s Selective Cytopheretic Device..
10/05/202307:30GLOBESeaStar Medical to Present at the Dawson James Small Cap..
10/03/202315:05GLOBESeaStar Medical Provides Regulatory Update Regarding..
9/29/202307:30GLOBEFDA Grants Breakthrough Device Designation to SeaStar..
9/21/202308:35GLOBEDawson James Securities Announces October Date for 8th..
8/30/202315:35EDGAR2Form 8-K - Current report
8/29/202307:00GLOBECase Series of Three Critically Ill Children with Acute..
8/24/202316:15EDGAR2Form 8-K - Current report
8/22/202307:00GLOBESeaStar Medical to Hold Business Update Conference Call..
8/17/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/17/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/17/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202315:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202315:43EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202315:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202315:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202305:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202305:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202305:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202305:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/15/202305:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202315:36EDGAR2Form PRE 14A - Other preliminary proxy statements
8/14/202315:35GLOBESeaStar Medical Reports Second Quarter 2023 Financial..
8/14/202315:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202315:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202315:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/10/202315:00EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
8/02/202315:19EDGAR2Form 8-K - Current report
7/31/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
7/20/202316:11EDGAR2Form S-1 - General form for registration of securities under..
7/05/202316:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Your Recent History

Delayed Upgrade Clock